Meeder Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	+10,392	New	+$248K	0.01%	275
2025 Q3	–	Sell	-2,957	Closed	-$64.2K	–	836
2025 Q2	$64.2K	Sell	2,957 -6,484	-69%	-$153K	﹤0.01%	342
2025 Q1	$229K	Sell	9,441 -2,392	-20%	-$53.9K	0.02%	236
2024 Q4	$247K	Buy	11,833 +7,336	+163%	+$158K	0.02%	205
2024 Q3	$89.4K	Hold	4,497	–	–	0.01%	303
2024 Q2	$69.7K	Buy	+4,497	New	+$70K	﹤0.01%	304
2023 Q1	–	Sell	-22	Closed	-$409	–	659
2022 Q4	$409	Sell	22 -75	-77%	-$1.16K	﹤0.01%	755
2022 Q3	$1K	Buy	+97	New	+$1.15K	﹤0.01%	1926
2021 Q4	–	Sell	-18,581	Closed	-$99K	–	1414
2021 Q3	$99K	Hold	18,581	–	–	0.01%	897
2021 Q2	$107K	Hold	18,581	–	–	0.01%	889
2021 Q1	$85K	Buy	+18,581	New	+$73.8K	﹤0.01%	955
2020 Q4	–	Sell	-18,582	Closed	-$55K	–	1945
2020 Q3	$55K	Hold	18,582	–	–	﹤0.01%	935
2020 Q2	$86K	Buy	18,582 +4,835	+35%	+$21.7K	0.01%	792
2020 Q1	$52K	Buy	13,747 +7,255	+112%	+$29.8K	﹤0.01%	891
2019 Q4	$25K	Buy	6,492 +3,100	+91%	+$14.5K	﹤0.01%	1278
2019 Q3	$19K	Sell	3,392 -9,859	-74%	-$52.5K	﹤0.01%	1329
2019 Q2	$50K	Buy	13,251 +11,548	+678%	+$49.9K	﹤0.01%	954
2019 Q1	$9K	Sell	1,703 -32,534	-95%	-$95.6K	﹤0.01%	1264
2018 Q4	$67K	Buy	34,237 +22,227	+185%	+$63.6K	0.01%	742
2018 Q3	$46K	Sell	12,010 -4,502	-27%	-$14.1K	﹤0.01%	799
2018 Q2	$51.5K	Buy	16,512 +14,200	+614%	+$43.1K	﹤0.01%	749
2018 Q1	$5K	Buy	2,312 +1,286	+125%	+$4.27K	﹤0.01%	1214
2017 Q4	$3K	Buy	+1,026	New	+$3.39K	﹤0.01%	1420